Overview
Description
Curaleaf Holdings Inc. is a prominent player in the cannabis industry, engaged primarily in the cultivation, processing, and sale of cannabis products. The company operates across the United States, offering a broad range of products that include cannabis-based therapeutic applications, edibles, tinctures, and vape oils, catering to both the medical and recreational cannabis markets. Curaleaf's extensive network includes dispensaries, cultivation sites, and production facilities, positioning it as a significant contributor to the cannabis sector's expansion. Its vertical integration strategy allows it to control the supply chain, ensuring consistency and quality in its offerings. Headquartered in Wakefield, Massachusetts, Curaleaf Holdings Inc. plays a crucial role in advocating for cannabis reform and market growth, reflecting broader societal shifts towards acceptance and regulatory changes in the cannabis landscape. As legal frameworks surrounding cannabis evolve, Curaleaf continues to adapt and expand, maintaining a formidable presence in the industry through strategic acquisitions and partnerships.
About
CEO
Mr. Boris Alexis Jordan
Employees
5519
Address
290 Harbor Drive
Suite 2035
Stamford, 06902, CT
United States
Suite 2035
Stamford, 06902, CT
United States
Phone
—
Website
Instrument type
Common stock
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
Canada
MIC code
XTSE